Clinical Trial Update: Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C. CINAM [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic study of amantadine and ribavirin in chronic hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)
• amantadine (amantadine)

Snippet

Sponsor: University Hospital, Limoges | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED